These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 27079931)

  • 1. Which influenza vaccine formulation should be used in Kenya? A comparison of influenza isolates from Kenya to vaccine strains, 2007-2013.
    Waiboci LW; Mott JA; Kikwai G; Arunga G; Xu X; Mayieka L; Emukule GO; Muthoka P; Njenga MK; Fields BS; Katz MA
    Vaccine; 2016 May; 34(23):2593-601. PubMed ID: 27079931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance for influenza--United States, 1997-98, 1998-99, and 1999-00 seasons.
    Brammer TL; Murray EL; Fukuda K; Hall HE; Klimov A; Cox NJ
    MMWR Surveill Summ; 2002 Oct; 51(7):1-10. PubMed ID: 12418623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of influenza viruses collected from young children in Uberlandia, Brazil - from 2001 to 2010.
    de Mattos Silva Oliveira TF; Yokosawa J; Motta FC; Siqueira MM; da Silveira HL; Queiróz DA
    BMC Infect Dis; 2015 Feb; 15():71. PubMed ID: 25886886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Both hemispheric influenza vaccine recommendations would have missed near half of the circulating viruses in Madagascar.
    Guillebaud J; Héraud JM; Razanajatovo NH; Livinski AA; Alonso WJ
    Influenza Other Respir Viruses; 2017 Nov; 11(6):473-478. PubMed ID: 29067783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimates of influenza vaccine effectiveness for 2007-2008 from Canada's sentinel surveillance system: cross-protection against major and minor variants.
    Janjua NZ; Skowronski DM; De Serres G; Dickinson J; Crowcroft NS; Taylor M; Winter AL; Hottes TS; Fonseca K; Charest H; Drews SJ; Sabaiduc S; Bastien N; Li Y; Gardy JL; Petric M
    J Infect Dis; 2012 Jun; 205(12):1858-68. PubMed ID: 22492921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season.
    Belongia EA; Kieke BA; Donahue JG; Greenlee RT; Balish A; Foust A; Lindstrom S; Shay DK;
    J Infect Dis; 2009 Jan; 199(2):159-67. PubMed ID: 19086915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interim within-season estimate of the effectiveness of trivalent inactivated influenza vaccine--Marshfield, Wisconsin, 2007-08 influenza season.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Apr; 57(15):393-8. PubMed ID: 18418344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The 2003/2004 influenza season in the Netherlands with a limited epidemic of the virus variant A/Fujian, and the vaccine composition for the 2004/2005 season].
    Rimmelzwaan GF; de Jong JC; Bartelds AI; Wilbrink B; Fouchier RA; Osterhaus AD
    Ned Tijdschr Geneeskd; 2004 Oct; 148(40):1984-8. PubMed ID: 15524136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The 2002/2003 influenza season in the Netherlands and the vaccine composition for the 2003/2004 season].
    de Jong JC; Rimmelzwaan GF; Bartelds AI; Wilbrink B; Fouchier RA; Osterhaus AD
    Ned Tijdschr Geneeskd; 2003 Oct; 147(40):1971-5. PubMed ID: 14574782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The evolving history of influenza viruses and influenza vaccines.
    Hannoun C
    Expert Rev Vaccines; 2013 Sep; 12(9):1085-94. PubMed ID: 24024871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza viruses circulating in Thailand in 2004 and 2005.
    Waicharoen S; Thawatsupha P; Chittaganpitch M; Maneewong P; Thanadachakul T; Sawanpanyalert P
    Jpn J Infect Dis; 2008 Jul; 61(4):321-3. PubMed ID: 18653981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update: influenza activity--United States and worldwide, 2002-03 season, and composition of the 2003-04 influenza vaccine.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Jun; 52(22):516-21. PubMed ID: 12803198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uptake and effectiveness of monovalent influenza A (H1N1) pandemic 2009 vaccine among healthcare personnel in Kenya, 2010.
    Njuguna H; Ahmed J; Oria PA; Arunga G; Williamson J; Kosgey A; Muthoka P; Mott JA; Breiman RF; Katz MA
    Vaccine; 2013 Sep; 31(41):4662-7. PubMed ID: 23859843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization and phylogenetic analysis of the hemagglutinin 1 protein of human influenza A virus subtype H1N1 circulating in Kenya during 2007-2008.
    Bulimo WD; Achilla RA; Majanja J; Mukunzi S; Wadegu M; Osunna F; Mwangi J; Njiri J; Wangui J; Nyambura J; Obura B; Mitei K; Omariba D; Segecha S; Nderitu M; Odindo A; Adega C; Kiponda J; Mupa R; Munyazi F; Kissinger G; Mwakuzimu M; Kamola D; Muhidin E; Kamau D; Kairithia S; Koech M; Sang A; Onge'ta L; Schnabel DC
    J Infect Dis; 2012 Dec; 206 Suppl 1():S46-52. PubMed ID: 23169971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine.
    Skowronski DM; Janjua NZ; Sabaiduc S; De Serres G; Winter AL; Gubbay JB; Dickinson JA; Fonseca K; Charest H; Bastien N; Li Y; Kwindt TL; Mahmud SM; Van Caeseele P; Krajden M; Petric M
    J Infect Dis; 2014 Jul; 210(1):126-37. PubMed ID: 24446529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [2000/01 influenza season and the vaccine composition for the season 2001/'02].
    de Jong JC; Rimmelzwaan GF; Bartelds AI; Wilbrink B; Fouchier RA; Osterhaus AD
    Ned Tijdschr Geneeskd; 2001 Oct; 145(40):1945-50. PubMed ID: 11675977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influenza in the 1994/95 season; composition of vaccine for the 1995/96 season].
    Claas EC; de Jong JC; Bartelds AI; Rimmelzwaan GF; van Wijngaarden JK; Osterhaus AD
    Ned Tijdschr Geneeskd; 1995 Oct; 139(42):2154-8. PubMed ID: 7477582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory-based surveillance and molecular epidemiology of influenza virus in Taiwan.
    Shih SR; Chen GW; Yang CC; Yang WZ; Liu DP; Lin JH; Chiu SC; Chen HY; Tsao KC; Huang CG; Huang YL; Mok CK; Chen CJ; Lin TY; Wang JR; Kao CL; Lin KH; Chen LK; Eng HL; Liu YC; Chen PY; Lin JS; Wang JH; Lin CW; Chan YJ; Lu JJ; Hsiung CA; Chen PJ; Su IJ
    J Clin Microbiol; 2005 Apr; 43(4):1651-61. PubMed ID: 15814980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influenza season 1999/2000 and vaccine composition for the season 2000/01].
    Rimmelzwaan GF; de Jong JC; Bartelds AI; Dorigo-Zetsma JW; Fouchier RA; Osterhaus AD
    Ned Tijdschr Geneeskd; 2000 Oct; 144(41):1968-71. PubMed ID: 11048562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results from the first 30 months of national sentinel surveillance for influenza in Tanzania, 2008-2010.
    Mmbaga VM; Mwasekaga MJ; Mmbuji P; Matonya M; Mwafulango A; Moshi S; Emukule G; Katz MA
    J Infect Dis; 2012 Dec; 206 Suppl 1():S80-6. PubMed ID: 23169977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.